1 in 4 people in the U.S. struggles with allergies, asthma or both. BRI has made significant breakthroughs in understanding how these conditions occur.
The Murdock Trust has granted BRI with more than $3 million over 30 years for state-of-the-art core equipment to support the research labs.
Scientists at BRI continue to look for better drugs and therapies as well as ways to eliminate multiple sclerosis.
BRI is relatively small compared to large research universities, but its impact goes well beyond its size and location through key collaborations with numerous external investigators.
Researchers at Benaroya Research Institute at Virginia Mason (BRI) used cutting-edge tetramer technology developed at BRI
Multiple sclerosis (MS) affects more than a million people worldwide including 15,000 in the Northwest.
The estate of Leonard and Majorie Wright of Mukilteo, Wash., recently bequeathed $2.5 million to BRI for translational research.
One of the nation’s greatest research treasures was developed at Benaroya Research Institute at Virginia Mason (BRI) and i
© 2020 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795